News Focus
News Focus
icon url

biopharm

09/03/17 1:29 PM

#310750 RE: revenue_monster #310749

Did you think it was just a coincidence it is called Peregrine, knowing this RNA would ultimately be used with biomarkers and/or Gene editing ?

It seems like you are discarding this info without knowing how these RNA would become known with PS Targeting....

It is the same as some that said Parker Cancer Institute would never have anything to do with Peregrine, yet they are proven wrong again as Sean Parker PCI has founding member Memorial Sloan Kettering lead researcher Dr Need Wolchok and using PS Targeting to prove how it reduces off target TOXICITIES and increase patient responders

Lots of more Info on the way.....
icon url

vinmantoo

09/03/17 2:19 PM

#310752 RE: revenue_monster #310749

We have developed a simple and cost-effective technique for preparing representative, strand-specific RNA-Seq libraries. In this technique, called “Peregrine,” short non-identical tag sequences are incorporated at the 5' and 3' ends of the first strand of cDNA during its synthesis. These tags preserve strand specificity information, and are used as



Nothing novel, impressive or valuable about this. It is just another attempted distraction from the failure of PPHM management. It is predictable and sad.